jlitten-large.jpg

Jason Litten, M.D.
Chief Medical Officer

Jason Litten, M.D., is the Chief Medical Officer at Optera Therapeutics Corp. Prior to Optera, Jason led Solid Tumor Oncology Development for Juno Therapeutics, Inc.  Before his time at Juno, Jason held leadership roles in clinical development at Clovis Oncology, Inc and Amgen Inc., where he led global registrational solid tumor oncology programs.  Prior to joining industry, Jason completed his fellowship in Pediatric Hematology / Oncology at UT Southwestern and an internship/residency at The University of Miami, Florida.  Jason received his MD from Emory University School of Medicine and his BS from Cornell University.